Skip to main content

Posters

March 02, 2019
Major Neurocognitive disorders with behavioral disturbance are commonly referred for psychiatric consultation. The use of anti-psychotics as a treatment modality in this population is highly scrutinized given increased risk of mortality in the elderly. Efficacy of Selective Serotonin Reuptake…
December 21, 2017
Neuropsychiatric symptoms (NPS) are associated with a worse quality of life and caregiver burden. We evaluated which symptoms caregivers most often selected as targets for treatment.
December 07, 2017
We set out to expand the dose range and document the effect of high current using Electroencephalogram.
December 07, 2017
Mr. TR was injured in a motor vehicle accident in 2010 and suffered a traumatic brain injury (TBI), which resulted in changes in his personality and behavior.
December 06, 2017
Little is known about the natural progression of agitation and its relationship to disease severity in AD/Dementia.
November 06, 2017
We sought to estimate the prevalence of agitation symptoms overall and by Alzheimer's disease severity.
January 24, 2017
The aim of this presentation is to discuss differential diagnosis of psychiatric conditions associated with central nervous system calcifications.
February 23, 2016
The "FIND" (Faith in New Dimensions) psychospiritual assessment tool has been developed specifically for the current older adult cohort. We have translated it into Spanish and Vietnamese languages. The "FIND" assessment tool explores in a non-threatening way for older adults characterizations of…
February 11, 2016
In 1977, Torch et al [NEUROLOGY 27:1157-64] described LATND in a 64y.o. man who died after an 8yr progressive history of behavioral, sleep/autonomic disturbance, Alzheimers-like dementia[AD], associated with left temporal EEG slowing. Autopsy revealed an old left-hippocampal infarct with atrophy of…
February 10, 2016
Background: In AD, progressive deterioration of cognition is associated with reduced function and quality of life. Encenicline is an alpha 7 nicotinic acetylcholine receptor agonist and has demonstrated enhanced cognitive function in patients with schizophrenia and Alzheimer's disease.
Back to Top